MedTrace Logo

Failure Analysis of Patellofemoral Arthroplasty

NCT04772625 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2025-07-30

No results posted yet for this study

Summary

The purpose of the retrospective cohort study is 1) to determine preoperative risk factors for revision af patellofemoral arthroplasty, and 2) to provide a detailed description of indications for revision after patellofemoral arthroplasty. All patients operated with patellofemoral arthroplasty in Denmark from January 1, 2008 to December 31, 2015, will be included in the cohort.

Conditions

Interventions

DEVICE

Patellofemoral arthroplasty

Insertion of an artificial joint between the front of the femur and the back of the patella. The femoral component consists of a metal implant, and the patellar component is a polyethylene implant. The two components replace the original articular cartilage of the patellofemoral joint.

Sponsors & Collaborators

  • Stryker Orthopaedics

    collaborator INDUSTRY

  • Anders Odgaard

    lead OTHER

Principal Investigators

  • Anders Odgaard, MD, DMSc · Rigshospitalet, Denmark

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-11-09
Completion
2026-04-01
FDA Device
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04772625 on ClinicalTrials.gov